Bercovich C F, Pirola C J, Finkielman S, Nahmod V E
Laboratorio de Sustancias Vasoactivas, Facultad de Medicina, Universidad de Buenos Aires, República Argentina.
Circ Shock. 1991 Feb;33(2):63-7.
Sodium o-iodobenzoate (OISB) produces an increase in P50 (PO2 at 50% of oxyhemoglobin saturation) and survival when infused at the time of initiation of prolonged hemorrhagic shock in dogs. Acid-base parameters improved during treatment, and plasma lactic acid concentrations showed smaller rises than in nontreated control animals. Erythrocyte 2,3-diphosphoglycerate (2,3-DPG) rose in prolonged hemorrhagic shock in the control group and conversely decreased in OISB-treated dogs. OISB did not require red cell integrity, since its effects were still more marked in hemolyzed blood. The therapeutic benefit of OISB, appears to be related to a direct effect of the agent on the hemoglobin molecule.
邻碘苯甲酸钠(OISB)在犬类长时间失血性休克开始时输注,可使P50(氧合血红蛋白饱和度为50%时的氧分压)升高并提高生存率。治疗期间酸碱参数得到改善,血浆乳酸浓度的升高幅度小于未治疗的对照动物。对照组犬在长时间失血性休克时红细胞2,3-二磷酸甘油酸(2,3-DPG)升高,而在接受OISB治疗的犬中则相反降低。OISB不需要红细胞完整,因为其在溶血血液中的作用仍然更显著。OISB的治疗益处似乎与该药物对血红蛋白分子的直接作用有关。